Apollo Endosurgery, Inc. (APEN) |
| 10 0 (0%) 04-03 16:00 |
| Open: | 9.93 |
| High: | 10 |
| Low: | 9.92 |
| Volume: | 1,639,528 |
| Market Cap: | 580(M) |
| PE Ratio: | -9.43 |
| Exchange: | NASDAQ Global Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 376.60 |
| Resistance 1: | 322.43 |
| Pivot price: | 318.83 |
| Support 1: | 318.65 |
| Support 2: | 316.32 |
| 52w High: | 10.3 |
| 52w Low: | 3.49 |
Apollo Endosurgery, Inc. is a medical technology firm specializing in the creation, development, and commercialization of advanced medical instruments. Among its products are the OverStitch and OverStitch Sx Endoscopic Suturing Systems, which empower physicians to perform advanced endoscopic procedures by suturing and securing tissue approximation via a flexible endoscope. The company also features the Orbera intragastric balloon system, available under brands such as Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System. This system aids in weight management by decreasing stomach capacity and slowing gastric emptying, thereby encouraging reduced food intake. Additionally, it provides the X-Tack Endoscopic HeliX Tacking System, a suture-based device designed for repairing defects in both the upper and lower gastrointestinal tract. Its medical solutions are distributed to various healthcare providers, including hospitals, outpatient surgical centers, clinics, and individual physicians, across the United States, Australia, Costa Rica, and several European nations. Founded in 2005, Apollo Endosurgery, Inc. maintains its headquarters in Austin, Texas.
| EPS | 4.070 |
| Book Value | 38.860 |
| PEG Ratio | 3.58 |
| Gross Profit | 25.895 |
| Profit Margin (%) | 10.67 |
| Operating Margin (%) | 10.52 |
| Return on Assets (ttm) | 6.4 |
| Return on Equity (ttm) | 11.4 |
Wed, 07 Jan 2026
Med tech company Boston Scientific readies for new Austin offices - Yahoo Finance
Wed, 07 Jan 2026
Med tech company begins renovations for new South Congress offices - Austin American-Statesman
Wed, 26 Apr 2023
Four things to know about our acquisition of Apollo Endosurgery - Boston Scientific
Tue, 04 Apr 2023
Boston Scientific completes Apollo Endosurgery acquisition - MassDevice
Wed, 30 Nov 2022
Why Boston Scientific (BSX) Is Buying Apollo Endosurgery (APEN) For $615 Million In Cash - Pulse 2.0
Wed, 30 Nov 2022
Boston Scientific shelling out $615M for Apollo Endosurgery - The Business Journals
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |